During the past decade, Lynn Institute of Norman conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 14 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 7 clinical trials were completed. i.e. 63.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lynn Institute of Norman" #1 sponsor was "Pfizer" with 5 trials, followed by "Allergan" with 2 trials sponsored, "BioNTech SE" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Emergent BioSolutions" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lynn Institute of Norman" #1 collaborator was "Integrium" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "CoLucid Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Lynn Institute of Norman" are "Episodic Migraine" (3 trials), "COVID-19" (2 trials), "Meningococcal Vaccines" (2 trials), "SARS-CoV-2 Infection" (2 trials) and "Type 2 Diabetes" (2 trials). Many other conditions were trialed in "Lynn Institute of Norman" in a lesser frequency.

Most popular intervention types in "Lynn Institute of Norman" are "Drug" (16 trials), "Biological" (11 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Atogepant" (2 trials), "BNT162b2" (2 trials), "Metformin XR" (2 trials) and "1% SPL7013 Gel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lynn Institute of Norman" are 25 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Lynn Institute of Norman". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Lynn Institute of Norman, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Lynn Institute of Norman, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".